CARAFATE SUSPENSION Rx
Select the drug indication to add to your list
CARAFATE SUSPENSION
Hyperacidity, GERD, and ulcers  Only 4 drugs may be compared at once
Remove Selected
Compare Selected
Generic Name and Formulations:
Sucralfate 1g/10mL.
Company:
Aptalis Pharmaceutical Technologies
 
Select therapeutic use: Hyperacidity, GERD, and ulcers
Indications for CARAFATE SUSPENSION:
Short-term (up to 8 weeks) treatment of active duodenal ulcer. Maintenance of healed duodenal ulcers (tabs only).

Adult:
Active: 1g 4 times daily on an empty stomach for 4–8 weeks. Maintenance: 1g 2 times daily.

Children:
Not established.

Warnings/Precautions:
Monitor for glycemia in diabetic patients. Chronic renal failure. Dialysis. Tabs: swallowing impairment (eg, recent or prolonged intubation, tracheostomy, history of aspiration, dysphagia, others). Pregnancy (Cat.B). Nursing mothers.

Interactions:
Avoid antacids within 30mins of dosing. May reduce absorption of tetracyclines, quinidine, levothyroxine, phenytoin, cimetidine, digoxin, ciprofloxacin, norfloxacin, ketoconazole, ranitidine, theophylline; dose concomitant drugs 2hrs before sucralfate. Additive aluminum load with aluminum-containing antacids. Monitor warfarin.

See Also:
CARAFATE

Pharmacological Class:
Cytoprotectant.

Adverse Reactions:
Constipation.

How Supplied:
Tabs—100; Susp—14oz